Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
- PMID: 37462699
- DOI: 10.1001/jama.2023.11330
Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
Abstract
Importance: Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood.
Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents.
Population: Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder.
Evidence assessment: The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined.
Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).
Comment in
-
Still "on the Fence" About Universal Childhood Lipid Screening: The USPSTF Reaffirms an I Statement.JAMA. 2023 Jul 18;330(3):225-227. doi: 10.1001/jama.2023.11258. JAMA. 2023. PMID: 37462716 No abstract available.
-
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.JAMA. 2023 Nov 28;330(20):2022-2023. doi: 10.1001/jama.2023.20449. JAMA. 2023. PMID: 38015223 No abstract available.
-
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.JAMA. 2023 Nov 28;330(20):2024. doi: 10.1001/jama.2023.20446. JAMA. 2023. PMID: 38015224 No abstract available.
-
USPSTF Recommendation on Screening for Lipid Disorders in Children and Adolescents.JAMA. 2023 Nov 28;330(20):2023-2024. doi: 10.1001/jama.2023.20443. JAMA. 2023. PMID: 38015225 No abstract available.
Summary for patients in
-
Screening for Lipid Disorders in Children and Adolescents.JAMA. 2023 Jul 18;330(3):292. doi: 10.1001/jama.2023.12762. JAMA. 2023. PMID: 37462703
Similar articles
-
Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2016 Aug 9;316(6):625-33. doi: 10.1001/jama.2016.9852. JAMA. 2016. PMID: 27532917
-
Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2016 Aug 9;316(6):634-44. doi: 10.1001/jama.2016.6423. JAMA. 2016. PMID: 27532918 Review.
-
Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Oct 18;328(15):1534-1542. doi: 10.1001/jama.2022.16946. JAMA. 2022. PMID: 36219440
-
Screening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: US Preventive Services Task Force Recommendation Statement.JAMA. 2023 Nov 7;330(17):1666-1673. doi: 10.1001/jama.2023.21408. JAMA. 2023. PMID: 37934215
-
Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.JAMA. 2022 Sep 13;328(10):963-967. doi: 10.1001/jama.2022.14543. JAMA. 2022. PMID: 36098719 Review.
Cited by
-
Prevalence of and factors associated with lipid screening in young people aged 16- to 21 years in the United States: analysis of nationwide cross-sectional data.Lipids Health Dis. 2024 Oct 26;23(1):350. doi: 10.1186/s12944-024-02336-1. Lipids Health Dis. 2024. PMID: 39462389 Free PMC article.
-
Prevalence and factors associated with dyslipidemia in children aged 6 to 42 months in a Brazilian capital.Cad Saude Publica. 2024 Sep 23;40(9):e00202123. doi: 10.1590/0102-311XEN202123. eCollection 2024. Cad Saude Publica. 2024. PMID: 39319924 Free PMC article.
-
Examining Food Security, Fruit and Vegetable Intake, and Cardiovascular Disease Risk Outcomes of Produce Prescription (PPR) Programs: A Systematic Review.J Nutr Educ Behav. 2024 Nov;56(11):794-821. doi: 10.1016/j.jneb.2024.06.012. Epub 2024 Aug 31. J Nutr Educ Behav. 2024. PMID: 39217534
-
Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.JAMA. 2024 Jun 4;331(21):1834-1844. doi: 10.1001/jama.2024.4819. JAMA. 2024. PMID: 38607340 Free PMC article.
-
Overcoming the real and imagined barriers to cholesterol screening in pediatrics.J Clin Lipidol. 2024 May-Jun;18(3):e297-e307. doi: 10.1016/j.jacl.2024.02.008. Epub 2024 Mar 6. J Clin Lipidol. 2024. PMID: 38485620 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
